Primary glomerulonephritis in Mainland China: An overview

Contributions to Nephrology

Volumn 181, Issue , 2013, Pages 1-11

  Xie, Jingyuan ^a   Chen, Nan ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CHINA; FOCAL GLOMERULOSCLEROSIS; GLOMERULONEPHRITIS; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; LIPOID NEPHROSIS; MEMBRANOUS GLOMERULONEPHRITIS; PATHOLOGY; PREVALENCE; REVIEW;

CHINA; GLOMERULONEPHRITIS; GLOMERULONEPHRITIS, IGA; GLOMERULONEPHRITIS, MEMBRANOUS; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; HUMANS; NEPHROSIS, LIPOID; PREVALENCE;

EID: 84958659696     PISSN: 03025144     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000348642     Document Type: Review

References (50)

1. Zhang L, Wang F, Wang L, Wang W, Liu B, Liu J, Chen M, He Q, Liao Y, Yu X, et al: Prevalence of chronic kidney disease in China: a cross-sectional survey. Lancet 2012; 379: 815-822.
2. Coresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, Eggers P, Van Lente F, Levey AS: Prevalence of chronic kidney disease in the United States. JAMA 2007; 298:2038-2047. (Pubitemid 350074801)
3. Chen N, Wang W, Huang Y, Shen P, Pei D, Yu H, Shi H, Zhang Q, Xu J, Lv Y, et al: Community-based study on CKD subjects and the associated risk factors. Nephrol Dial Transplant 2009; 24:2117-2123.
4. Chen N, Ma XB, Zhang JY, Mao PJ, He LQ, Yu JP, Ding XQ, Jiang GR, Gu Y, Zhang W, Wang NS, Mei CL, Ni ZH: Multicenter epidemiology survey of chronic kidney disease in the departments of nephrology in eastern China. 48th ERA-EDTA Congress, Prague, June 23-26, 2011.
5. Zhou FD, Zhao MH, Zou WZ, Liu G, Wang H: The changing spectrum of primary glo-merular diseases within 15 years: a survey of 3, 331 patients in a single Chinese centre. Nephrol Dial Transplant 2009; 24:870-876.
6. Li LS, Liu ZH: Epidemiologic data of renal diseases from a single unit in China: analysis based on 13, 519 renal biopsies. Kidney Int 2004; 66:920-923.
7. Braden GL, Mulhern JG, O'Shea MH, Nash SV, Ucci AA Jr, Germain MJ: Changing incidence of glomerular diseases in adults. Am J Kidney Dis 2000; 35:878-883. (Pubitemid 30238200)
8. Gesualdo L, Di Palma AM, Morrone LF, Strippoli GF, Schena FP: The Italian experience of the national registry of renal biopsies. Kidney Int 2004; 66:890-894. (Pubitemid 39120987)
9. Sugiyama H, Yokoyama H, Sato H, Saito T, Kohda Y, Nishi S, Tsuruya K, Kiyomoto H, Iida H, Sasaki T, et al: Japan Renal Biopsy Registry: the first nationwide, web-based, and prospective registry system of renal biopsies in Japan. Clin Exp Nephrol 2011; 15:493-503.
10. Li J, Sun L, Sun ZG, Wang B, Bai LL, Zhao ZY: Analysis of 1, 042 cases renal biopsy in Dalian area. J Dalian Med Univ 2011; 33:492.
11. Wu YQ, Wang Z, Xu HF, Jin XM, Zhou HZ: Frequency of primary glomerular disease in northeastern China. Braz J Med Biol Res 2011; 44:810-813.
12. Yue H, Xu SR, Lu C, Liu WL, Jiang H, Song X, Qiao LP, AL: Analysis of the epidemiology and pathologic types of 1, 323 patients undergoing renal biopsy. China Clin Pract Med 2008; 2:59.
13. Zhao XY, Jia YF: Analysis of the Epidemiology and Pathologic Types of 616 Primary Glomerular Disease in Inner Mongolia, Chi-feng Region. Hohhot, Inner Mongolia Medical College, 2010.
14. Lin HP, Liu HF: Analysis of 1, 627 Renal Clinical and Biopsy Data. Guangdong, Guangdong Medical College, 2008.
15. Cao Q, Huang WY, Xu H, Zhou LJ: Longterm effects of cyclosporin A in children with steroid-resistant idiopathic nephrotic syndrome and outcomes of the patients (in Chinese). Zhonghua er ke za zhi (Chin J Pediatr) 2008; 46:698-701.
16. Li H, Shi X, Shen H, Li X, Wang H, Xu G, Chen J: Tacrolimus versus intravenous pulse cyclophosphamide therapy in Chinese adults with steroid-resistant idiopathic minimal change nephropathy: a multicenter, open-label, nonrandomized cohort trial. Clin Ther 2012; 34:1112-1120.
17. Report of the International Study of Kidney Disease in Children: Nephrotic syndrome in children: prediction of histopathology from clinical and laboratory characteristics at time of diagnosis. Kidney Int 1978; 13:159-165.
18. Zhu B, Chen N, Wang ZH, Pan XX, Ren H, Zhang W, Wang WM: Identification and functional analysis of a novel TRPC6 mutation associated with late onset familial focal segmental glomerulosclerosis in Chinese patients. Mutat Res 2009; 664:84-90.
19. Genovese G, Friedman DJ, Ross MD, Lecor-dier L, Uzureau P, Freedman BI, Bowden DW, Langefeld CD, Oleksyk TK, Uscinski Knob AL, et al: Association of trypanolytic ApoL1 variants with kidney disease in African-Americans. Science 2010; 329:841-845.
20. D'Agati VD, Kaskel FJ, Falk RJ: Focal segmental glomerulosclerosis. N Engl J Med 2011; 365:2398-2411.
21. KDIGO Clinical Practice Guideline for Glo-merulonephritis. Kidney Int Suppl 2012; 2:181.
22. Cattran DC, Rao P: Long-term outcome in children and adults with classic focal segmental glomerulosclerosis. Am J Kidney Dis 1998; 32:72-79.
23. Ren H, Shen P, Li X, Pan XX, Zhang W, Chen N: Tacrolimus versus cyclophospha-mide in steroid-dependent or steroid-resistant focal segmental glomerulosclerosis: a randomized controlled trial. Am J Nephrol 2013; 37:84-90.
24. Fan L, Liu Q, Liao Y, Li Z, Ji Y, Yang Z, Chen J, Fu J, Zhang J, Kong Y, et al: Tacrolimus is an alternative therapy option for the treatment of adult steroid-resistant nephrotic syndrome: a prospective, multicenter clinical trial. Int Urol Nephrol 2012 (E-pub ahead of print).
25. Hao X, Xie J, Ma J, Zhou Q, Xue W, Ren H, Chen N: Increased risk of treatment failure and end-stage renal disease in familial FSGS. J Am Soc Nephrol 2012; 23:535A.
26. Kiryluk K, Li Y, Sanna-Cherchi S, Rohaniza-degan M, Suzuki H, Eitner F, Snyder HJ, Choi M, Hou P, Scolari F, et al: Geographic differences in genetic susceptibility to IgA nephropathy: GWAS replication study and geospatial risk analysis. PLoS Genet 2012; 8:e1002765.
27. Xie J, Kiryluk K, Wang W, Wang Z, Guo S, Shen P, Ren H, Pan X, Chen X, Zhang W, et al: Predicting progression of IgA nephropa-thy: new clinical progression risk score. PLoS One 2012; 7:e38904.
28. Donadio JV, Grande JP: IgA nephropathy. N Engl J Med 2002; 347:738-748. (Pubitemid 35203906)
29. Goto M, Wakai K, Kawamura T, Ando M, Endoh M, Tomino Y: A scoring system to predict renal outcome in IgA nephropathy: a nationwide 10-year prospective cohort study. Nephrol Dial Transplant 2009; 24:3068-3074.
30. Berthoux F, Mohey H, Laurent B, Mariat C, Afiani A, Thibaudin L: Predicting the risk for dialysis or death in IgA nephropathy. J Am Soc Nephrol 2011; 22:752-761.
31. Shi SF, Wang SX, Jiang L, Lv JC, Liu LJ, Chen YQ, Zhu SN, Liu G, Zou WZ, Zhang H, et al: Pathologic predictors of renal outcome and therapeutic efficacy in IgA nephropathy: validation of the oxford classification. Clin J Am Soc Nephrol 2011; 6:2175-2184.
32. Zeng CH, Le W, Ni Z, Zhang M, Miao L, Luo P, Wang R, Lv Z, Chen J, Tian J, et al: A multicenter application and evaluation of the oxford classification of IgA nephropathy in adult Chinese patients. Am J Kidney Dis 2012; 60:812-820.
33. Lv J, Zhang H, Zhou Y, Li G, Zou W, Wang H: Natural history of immunoglobulin A ne-phropathy and predictive factors of prognosis: a long-term follow up of 204 cases in China. Nephrology (Carlton) 2008; 13:242-246. (Pubitemid 351341460)
34. Shi Y, Chen W, Jalal D, Li Z, Mao H, Yang Q, Johnson RJ, Yu X: Clinical outcome of hyper-uricemia in IgA nephropathy: a retrospective cohort study and randomized controlled trial. Kidney Blood Press Res 2012; 35:153-160.
35. Schena FP, Cerullo G, Rossini M, Lanzilotta SG, D'Altri C, Manno C: Increased risk of end-stage renal disease in familial IgA ne-phropathy. J Am Soc Nephrol 2002; 13:453-460. (Pubitemid 34106288)
36. Izzi C, Ravani P, Torres D, Prati E, Viola BF, Guerini S, Foramitti M, Frasca G, Amoroso A, Ghiggeri GM, et al: IgA nephropathy: the presence of familial disease does not confer an increased risk for progression. Am J Kidney Dis 2006; 47:761-769.
37. Feehally J, Farrall M, Boland A, Gale DP, Gut I, Heath S, Kumar A, Peden JF, Maxwell PH, Morris DL, et al: HLA has strongest association with IgA nephropathy in genome-wide analysis. J Am Soc Nephrol 2010; 21:1791-1797.
38. Gharavi AG, Kiryluk K, Choi M, Li Y, Hou P, Xie J, Sanna-Cherchi S, Men CJ, Julian BA, Wyatt RJ, et al: Genome-wide association study identifies susceptibility loci for IgA ne-phropathy. Nat Gen 2011; 43:321-327.
39. Yu XQ, Li M, Zhang H, Low HQ, Wei X, Wang JQ, Sun LD, Sim KS, Li Y, Foo JN, et al: A genome-wide association study in Han Chinese identifies multiple susceptibility loci for IgA nephropathy. Nat Genet 2012; 44: 178-182.
40. Chen N, Nusbaum P, Halbwachs-Mecarelli L, Lesavre P: Light-chain composition of serum IgA1 and in vitro IgA1 production in IgA nephropathy. Nephrol Dial Transplant 1991; 6:846-850.
41. Liu LJ, Lv JC, Shi SF, Chen YQ, Zhang H, Wang HY: Oral calcitriol for reduction of proteinuria in patients with IgA nephropa-thy: a randomized controlled trial. Am J Kidney Dis 2012; 59:67-74.
42. Goumenos DS, Davlouros P, El Nahas AM, Ahuja M, Shortland JR, Vlachojannis JG, Brown CB: Prednisolone and azathioprine in IgA nephropathy-a ten-year follow-up study. Nephron Clin Pract 2003; 93:C58-C68.
43. Frisch G, Lin J, Rosenstock J, Markowitz G, D'Agati V, Radhakrishnan J, Preddie D, Crew J, Valeri A, Appel G: Mycophenolate mofetil vs. placebo in patients with moderately advanced IgA nephropathy: a double-blind randomized controlled trial. Nephrol Dial Transplant 2005; 20:2139-2145. (Pubitemid 41510089)
44. Tang S, Leung JC, Chan LY, Lui YH, Tang CS, Kan CH, Ho YW, Lai KN: Mycopheno-late mofetil alleviates persistent proteinuria in IgA nephropathy. Kidney Int 2005; 68:802-812. (Pubitemid 43323137)
45. Beck LH Jr, Bonegio RG, Lambeau G, Beck DM, Powell DW, Cummins TD, Klein JB, Salant DJ: M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med 2009; 361:11-21.
46. Li J, Zhang YM, Qu Z, Zhao MH, Liu G: Low-dose cyclosporine treatment in Chinese nephrotic patients with idiopathic membranous nephropathy: an uncontrolled study with prospective follow-up. Am J Med Sci 2010; 339:532-536.
47. Chen M, Li H, Li XY, Lu FM, Ni ZH, Xu FF, Li XW, Chen JH, Wang HY: Tacrolimus combined with corticosteroids in treatment of nephrotic idiopathic membranous ne-phropathy: a multicenter randomized controlled trial. Am J Med Sci 2010; 339:233-238.
48. Chen W, Liu Q, Liao Y, Yang Z, Chen J, Fu J, Zhang J, Kong Y, Fu P, Lou T, et al: Outcomes of tacrolimus therapy in adults with refractory membranous nephrotic syndrome: a prospective, multicenter clinical trial. Am J Med Sci 2013; 345:81-87.
49. Sethi S, Fervenza FC: Membranoproliferative glomerulonephritis-a new look at an old entity. N Engl J Med 2012; 366:1119-1131.
50. Fakhouri F, Fremeaux-Bacchi V, Noel LH, Cook HT, Pickering MC: C3 glomerulopathy: a new classification. Nat Rev Nephrol 2010; 6: 494-499.